MAPK3 and central nervous system cancer: In our case, the ID3288 compound dose-dependently stimulated Erk1/2 in human glioma cells of U251 line, while the temozolomide acted oppositely dose-dependently inhibiting this kinase, and doxorubicin did not affect it significantly (29,34-36).